Kini G D, Beadle J R, Xie H, Aldern K A, Richman D D, Hostetler K Y
Department of Medicine, University of California, San Diego, La Jolla 92093-0676, USA.
Antiviral Res. 1997 Sep;36(1):43-53. doi: 10.1016/s0166-3542(97)00039-9.
The identification of more effective and less toxic foscarnet (PFA) analogs for antiviral therapy would be useful. We recently synthesized 1-O-octadecyl-sn-glycero-3-phosphonoformic acid (ODG-PFA) and noted a 93-fold increase in its anti-HCMV activity relative to PFA. In addition, the antiviral activity of ODG-PFA in herpes simplex virus type-1 (HSV-1) and human immunodeficiency virus type-1 (HIV-1) infected cells was increased 40-fold relative to PFA (Hostetler et al., 1996. Antiviral Res. 31, 59). To evaluate structure-activity relationships further, we synthesized alkoxypropyl esters of foscarnet with varying alkyl chain lengths and degrees of saturation. These compounds were tested in vitro for activity and selectivity in comparison with PFA and ODG-PFA in cells infected with HCMV, HSV-1 or HIV-1. Antiviral activity was strongly dependent on chain length with alkyl ethers 14-18 carbon atoms long exhibiting the greatest antiviral activity against HCMV and HSV-1. In HIV-infected HT4-6C cells, optimal activity was observed at 18-22 carbon chain lengths. The antiviral activities of 1-octadecyloxypropane-3-PFA and 1-docosyloxypropane-3-PFA were 135- and 338-fold greater than that of PFA in HT4-6C cells infected with HIV-1. This also represents a 2.6-6-fold improvement in antiviral activity over ODG-PFA, the previously reported analog.
鉴定出更有效且毒性更低的膦甲酸钠(PFA)类似物用于抗病毒治疗将很有帮助。我们最近合成了1-O-十八烷基-sn-甘油-3-膦酰甲酸(ODG-PFA),并注意到其抗人巨细胞病毒(HCMV)活性相对于PFA增加了93倍。此外,ODG-PFA在单纯疱疹病毒1型(HSV-1)和人类免疫缺陷病毒1型(HIV-1)感染细胞中的抗病毒活性相对于PFA增加了40倍(Hostetler等人,1996年。抗病毒研究。31,59)。为了进一步评估构效关系,我们合成了具有不同烷基链长度和饱和度的膦甲酸钠的烷氧基丙酯。将这些化合物与PFA和ODG-PFA一起在感染HCMV、HSV-1或HIV-1的细胞中进行体外活性和选择性测试。抗病毒活性强烈依赖于链长度,具有14-18个碳原子的烷基醚对HCMV和HSV-1表现出最大的抗病毒活性。在HIV感染的HT4-6C细胞中,在碳链长度为18-22时观察到最佳活性。在感染HIV-1的HT4-6C细胞中,1-十八烷氧基丙烷-3-PFA和1-二十二烷氧基丙烷-3-PFA的抗病毒活性分别比PFA高135倍和338倍。这也代表了相对于先前报道的类似物ODG-PFA,抗病毒活性提高了2.6-6倍。